RION Co (FRA:G73) ROCE %: 14.88% (As of Mar. 2026)

What is RION Co ROCE %?

RION Co FRA:G73 60 ROCE % is 14.88% as of Mar. 2026. GuruFocus rates FRA:G73 with a GF Score™ of 60/100 and a GF Value™ of €14.25 (Significantly Overvalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. RION Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 14.88%.

RION Co (FRA:G73) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

RION Co ROCE % Related Terms

RION Co ROCE % Historical Data

* Premium members only.

The historical data trend for RION Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RION Co ROCE % Chart

RION Co Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

11.40

7.81

10.72

11.38

11.52

RION Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															10.27	9.45	13.02	12.17	14.88

60GF Score

RION Co Ltd FRA:G73

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

RION Co ROCE % Calculation

RION Co's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	23.852	/	( ( (259.297 - 28.721)	+	(213.317 - 29.735) )	/ 2 )
	=	23.852	/	( (230.576	+	183.582)	/ 2 )
	=	23.852	/	207.079
	=	11.52 %

RION Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	28.04	/	( ( (216.801 - 23.386)	+	(213.317 - 29.735) )	/ 2 )
	=	28.04	/	( ( 193.415	+	183.582 )	/ 2 )
	=	28.04	/	188.4985
	=	14.88 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 14.88% mean?

RION Co (FRA:G73) has a ROCE % of 14.88% as of Mar. 2026.

Is RION Co's ROCE % too high?

RION Co's current ROCE % is 14.88%. The Medical Devices & Instruments industry median ROCE % is 2.23. RION Co's value of 14.88% is 567.3% above this industry median. Overall, RION Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does RION Co's ROCE % compare to ABT and SYK?

RION Co's ROCE % of 14.88% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. RION Co's value of 14.88% is 567.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RION Co's current ROCE % of 14.88% is 567.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RION Co's current ROCE % is 14.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is RION Co stock overvalued right now?

Based on GuruFocus' analysis, RION Co (FRA:G73) is currently considered Significantly Overvalued. The stock's GF Value™ is €14.25, compared to a current price of €20.80 — trading 46% above its estimated fair value. The current ROCE % is 14.88% and 567.3% above the Medical Devices & Instruments industry median of 2.23. RION Co's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For RION Co (FRA:G73), the current ROCE % is 14.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RION Co (FRA:G73) Overvalued in 2026?

Based on GuruFocus' analysis, RION Co stock appears to be overvalued. The current stock price of €20.80 is trading 46% above its estimated GF Value™ of €14.25. GuruFocus considers RION Co to be Significantly Overvalued.

Key valuation signals for FRA:G73:

ROCE %: 14.88%
GF Value™: €14.25 vs. price of €20.80 (46% above fair value)
GF Score™: 60/100 with 6 warning signs
Industry Position: 567.3% above the Medical Devices & Instruments median

No single metric tells the full story. See the FRA:G73 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RION Co Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TSE:4548 TSE:7777 TSE:7779 TSE:7600 TSE:4889 TSE:6678 TSE:7792 TSE:3079 TSE:9341 TSE:5187 ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges 6823:Japan

Address 3-20-41 Higashimotomachi, Kokubunji, Tokyo, JPN, 185-8533

Website http://www.rion.co.jp

RION Co Ltd is engaged in manufacturing and selling of maintenance services of a medical device. The company offers hearing instruments and medical equipment, an environmental device including sound and vibration measuring instruments and particle counters and parts and equipment.

60GF Score

Get the complete analysis for FRA:G73

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.80

Price

€14.25

GF Value

View FRA:G73 Analysis

See ROCE % data for all stocks →